A new concept from the award-winning Cocoa Mint brand, Cocoa Mint Studio, was previewed at Mido. Inspired by bold shapes and seasonal colours, the collection features oversized silhouettes and a fresh palette, delivering wearable high-fashion pieces infused with Cocoa Mint’s signature relaxed-glamou
Blackfin has launched AirGlass, a revolutionary new Barberini polarised lens in ultra-thin glass, seeking to redefine the balance between weight and optical quality.
Glaucoma poses a significant threat to vision if left untreated. With 112 million people estimated to be affected by 20401, it ranks globally as the second leading cause of blindness2, emphasising the essential role of adherence to ocular hypertensive medications in preventing irreversible vision lo
Colour was front and centre at the Dutch brand Dutz’s Mido and Opti booths. Its latest collection features bold colours and quirky shapes for the brave but also offers more earthy nuances in wearable shapes for him and her.
Face à Face’s latest Japan Now collection, inspired by contemporary Japanese design, is creative with unexpected elements and stand-out colours. Model Matics, featured here, transforms mechanical components with an aesthetic bias, showcasing functional components, such as the customarily hidden rim
A new shared-care e-Learning course for implantable collamer lenses (ICL) for optometrists in New Zealand and Australia has been unveiled by Device Technologies in collaboration with Staar Surgical.
International consortium BIENCO has been awarded AU$35 million to further the development of bioengineered eye tissue to treat corneal blindness.
Located in the heart of Auckland’s CBD, optometrist trio Dr Vivienne Zhang, Charisse Kuo and Gina Partridge have opened New Zealand’s first clinic specialising in myopia management: the Auckland Myopia Clinic.
Aspen Pharmacare’s Eikance 0.01% atropine drops have been approved by Medsafe and will be available via prescription from pharmacies in New Zealand from the end of June 2024.
University of Auckland research fellow and lecturer Dr Alyssa Lie has been awarded one of two inaugural Catalyst Awards by the Association for Research in Vision and Ophthalmology (ARVO) to advance her research into age-related eye diseases.
A US study found an artificial intelligence (AI) system matched, or in some cases outperformed, experienced ophthalmologists in their diagnoses and proposed treatments for glaucoma and retinal disease
Early data from the phase 2 trial of gene therapy Ixo-vec (ixoberogene soroparvovec, formerly ADVM-022), demonstrated potential best-in-class clinical activity in treatment burden reduction for “hard
